Implantable cardioverter‐defibrillators with end stage renal disease: Nationwide inpatient sample database results
- 22 November 2021
- journal article
- research article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 45 (1) , 124-131
Abstract
Background: When compared to patients with normal renal function, patients with chronic kidney disease develop higher in‐hospital complications post implantable cardioverter‐defibrillator (ICD) therapy. However, real world data on in‐hospital complications post ICD therapy in patients with end stage renal disease (ESRD) is limited. In this study, we aim to explore the procedure‐related complications of ICD therapy in patients with ESRD.Methods: Using the nationwide inpatient sample (NIS) database, we conducted a retrospective analysis on ESRD patients who underwent inpatient ICD placement from 2010 to 2016. Using 1:2 propensity score matching, we compared ESRD patients to those with normal renal function. Outcomes of interest were postoperative hemorrhage and hematoma formation, blood transfusion, pericardial complications, mechanical complications requiring lead revision, vascular injury, in‐hospital mortality, and length of stay.Results: Our sample included 40,075 cases with subsequent propensity score matching between ESRD and normal renal function. Comparatively, patients with ESRD had higher odds of postoperative hemorrhage (Odds ratio [OR] = 1.67, 95% confidence interval [CI] 1.4–1.99, p = < .0001), blood transfusion (OR, 3.88; CI 3.29–4.56; p = < .0001), mechanical complications requiring lead revision (OR, 1.24; CI 1.01–1.51; p = .035), vascular injury (OR, 2.02; CI 1.27–3.24; p = .0027), in‐hospital mortality (OR, 4.56; CI 3.08–6.76; p = < .0001), and longer hospitalization (11 vs. 7 days, p = < .0001), but without significant difference in pericardial complications (OR, 1.9; CI 0.92–1.54; p = < .18).Conclusion: In this large contemporary cohort, patients with ESRD undergoing inpatient ICD therapy are at higher risk of developing postprocedural complications including hemorrhage and hematoma, blood transfusion, mechanical complications requiring lead revision, and in hospital mortality, without increased risk of pericardial complications.Keywords
This publication has 31 references indexed in Scilit:
- Early Outcomes among Those Initiating Chronic Dialysis in the United StatesClinical Journal of the American Society of Nephrology, 2011
- Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United StatesAmerican Journal of Kidney Diseases, 2011
- Defibrillator Implantation Early after Myocardial InfarctionNew England Journal of Medicine, 2009
- Impact of Renal Function on Survival in Patients with Implantable Cardioverter‐DefibrillatorsPacing and Clinical Electrophysiology, 2007
- Chronic Renal Insufficiency Is an Independent Predictor of Mortality in Implantable Cardioverter‐Defibrillator RecipientsPacing and Clinical Electrophysiology, 2007
- HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Neutrophil Dysfunction and Infection Risk in End‐Stage Renal DiseaseSeminars in Dialysis, 2006
- Cigarette Smoking and the Risk of Supraventricular and Ventricular Tachyarrhythmias in High‐Risk Cardiac Patients with Implantable Cardioverter DefibrillatorsJournal of Cardiovascular Electrophysiology, 2006
- Characteristics of sudden death in hemodialysis patientsKidney International, 2006
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002